88 related articles for article (PubMed ID: 25149066)
21. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
[TBL] [Abstract][Full Text] [Related]
22. L1 cell adhesion molecule (L1CAM) in invasive tumors.
Raveh S; Gavert N; Ben-Ze'ev A
Cancer Lett; 2009 Sep; 282(2):137-45. PubMed ID: 19144458
[TBL] [Abstract][Full Text] [Related]
23. L1CAM in human cancer.
Altevogt P; Doberstein K; Fogel M
Int J Cancer; 2016 Apr; 138(7):1565-76. PubMed ID: 26111503
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
25. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus.
Ding S; Liang Y; Zhao M; Liang G; Long H; Zhao S; Wang Y; Yin H; Zhang P; Zhang Q; Lu Q
Arthritis Rheum; 2012 Sep; 64(9):2953-63. PubMed ID: 22549634
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
[TBL] [Abstract][Full Text] [Related]
27. L1 cell adhesion molecule induces melanoma cell motility by activation of mitogen-activated protein kinase pathways.
Yi YS; Baek KS; Cho JY
Pharmazie; 2014 Jun; 69(6):461-7. PubMed ID: 24974583
[TBL] [Abstract][Full Text] [Related]
28. microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma.
Wang Q; Huang Z; Guo W; Ni S; Xiao X; Wang L; Huang D; Tan C; Xu Q; Zha R; Zhang J; Sheng W; He X; Du X
Clin Cancer Res; 2014 Mar; 20(5):1146-57. PubMed ID: 24327274
[TBL] [Abstract][Full Text] [Related]
29. Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent.
Schäfer H; Geismann C; Heneweer C; Egberts JH; Korniienko O; Kiefel H; Moldenhauer G; Bachem MG; Kalthoff H; Altevogt P; Sebens S
Carcinogenesis; 2012 Jan; 33(1):84-93. PubMed ID: 22095073
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer.
Cao J; Song Y; Bi N; Shen J; Liu W; Fan J; Sun G; Tong T; He J; Shi Y; Zhang X; Lu N; He Y; Zhang H; Ma K; Luo X; Lv L; Deng H; Cheng J; Zhu J; Wang L; Zhan Q
Cancer Res; 2013 Jun; 73(11):3326-35. PubMed ID: 23592755
[TBL] [Abstract][Full Text] [Related]
31. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
Zhai Q; Zhou L; Zhao C; Wan J; Yu Z; Guo X; Qin J; Chen J; Lu R
Biochem Biophys Res Commun; 2012 Mar; 419(4):621-6. PubMed ID: 22369946
[TBL] [Abstract][Full Text] [Related]
32. L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population.
Terraneo N; Jacob F; Peitzsch C; Dubrovska A; Krudewig C; Huang YL; Heinzelmann-Schwarz V; Schibli R; Béhé M; Grünberg J
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31952346
[TBL] [Abstract][Full Text] [Related]
33. Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion.
Li Y; Galileo DS
Cancer Cell Int; 2010 Sep; 10():34. PubMed ID: 20840789
[TBL] [Abstract][Full Text] [Related]
34. Druggable genetic targets in endometrial cancer
Lehrer S; Rheinstein PH
Cancer Treat Res Commun; 2022; 30():100502. PubMed ID: 34933203
[TBL] [Abstract][Full Text] [Related]
35. The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis.
Giannini A; D'Oria O; Corrado G; Bruno V; Sperduti I; Bogani G; Laganà AS; Chiantera V; Caserta D; Vizza E
Arch Gynecol Obstet; 2024 Mar; 309(3):789-799. PubMed ID: 37454351
[TBL] [Abstract][Full Text] [Related]
36. L1CAM deployed perivascular tumor niche promotes vessel wall invasion of tumor thrombus and metastasis of renal cell carcinoma.
Wu Z; Wu Y; Liu Z; Song Y; Ge L; Du T; Liu Y; Liu L; Liu C; Ma L
Cell Death Discov; 2023 Apr; 9(1):112. PubMed ID: 37015905
[TBL] [Abstract][Full Text] [Related]
37. ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor progression.
Li L; Wang X; Hu K; Liu X; Qiu L; Bai C; Cui Y; Wang B; Wang Z; Wang H; Cheng R; Hua J; Hai L; Wang M; Liu M; Song Z; Xiao C; Li B
Oncogene; 2023 Jun; 42(27):2166-2182. PubMed ID: 37221223
[TBL] [Abstract][Full Text] [Related]
38. Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells.
Tochigi H; Kajihara T; Mizuno Y; Mizuno Y; Tamaru S; Kamei Y; Okazaki Y; Brosens JJ; Ishihara O
Sci Rep; 2017 Apr; 7():46591. PubMed ID: 28443632
[No Abstract] [Full Text] [Related]
39. Targeting L1CAM and DDR1 may reduce bone metastasis in NSCLC.
Bonekey Rep; 2012; 1():75. PubMed ID: 23951468
[No Abstract] [Full Text] [Related]
40. Author Correction: L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer.
Ganesh K; Basnet H; Kaygusuz Y; Laughney AM; He L; Sharma R; O'Rourke KP; Reuter VP; Huang YH; Turkekul M; Er EE; Masilionis I; Manova-Todorova K; Weiser MR; Saltz LB; Garcia-Aguilar J; Koche R; Lowe SW; Pe'er D; Shia J; Massagué J
Nat Cancer; 2020 Nov; 1(11):1128. PubMed ID: 35122071
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
